当前位置: 首页 > 期刊 > 《基础医学与临床》 > 2000年第2期
编号:10686952
红细胞生成素的临床研究进展
http://www.100md.com 《基础医学与临床》 2000年第2期
     林沁 姜洪 杨秀玉 林沁(南京军区福州总医院,福州350025);姜洪(南京军区福州总医院,福州350025);杨秀玉(北京协和医院,北京100730) 基础医学与临床 2000 0 20 2


    关键词: 期刊 jcyxylc 0 集落刺激因子临床研究进展专题 fur -->


    

中图分类号:R331.14 文献标识码:A

    文章编号:1001-6325(2000)02-0009-03

Abstract :Erythropoietin(EPO) isthe primary growth factor for the red cell lineage.Recombinant human erythropoietin hasbeen produced by genetic technology since 1985 and since then many clinical trials haverepeatedly demonstrated its success in the correction of anamia associated with chronicrenal failure,cancer-related anemia,HIV infection, myelodysplasia,reheumatoidarthritis,matermal and neonatal anamia.Other uses of EPO under investigation arein perioperative surgery ......


您现在查看是摘要页,全文长 14335 字符